# Trade Mark Journal No.2026/003 16 January 2026

## WO0000001881964 (5)

Office of origin: United States of America

Date of International Registration:23 September 2025
Date of designation in the UK: 23 September 2025

International priority date claimed: 25 March 2025 (United States of America) (99103035)

Class 5
  Medicinal preparations for the treatment and prevention of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the treatment of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the prevention of lymphopenia, cancer, and infectious diseases; biological preparations for the treatment of lymphopenia, cancer, and infectious diseases; biological preparations for the prevention of lymphopenia, cancer, and infectious diseases; vaccines.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA